The Efficacy of Sonidegib in Treating Locally Advanced Basal Cell Carcinoma Involving the Periocular Area.
Alessia VillaniGabriella FabbrociniGiuseppe MicaliLuigi FornaroLuca PotestioMassimiliano ScalvenziPublished in: Dermatology and therapy (2023)
To the best of our knowledge, this is the first study investigating the effectiveness and safety of sonidegib in the management of BCC localized at the periocular region. Even if limited, our study suggests this drug as a valuable and safe option in periocular BCC management.